Chemical Structure (Zif00 0003 01)
Komzifti Capsule
Product Images NDC 84696-200
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Komzifti (NDC 84696-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Kura Oncology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (200 mg Bottle Label)
This text contains information about a medication called Komazifti (Ziftomenib) capsules, with each capsule containing 200 mg of the active ingredient. The product is manufactured for Kura Oncology, Inc. in San Diego, California. It also mentions the marketing collaboration with Kyowa Kirin Co., Ltd. The recommended dosage and storage instructions are provided, emphasizing not to open, break, or chew the capsules. The NDC number and a copyright notice for 2025 are included in the text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
